Rydan Pharmaceuticals Private Limited, a active private limited company, was established on 14 June 2019 in Jaipur, Rajasthan, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24299RJ2019PTC065317. Registered under ROC Roc Jaipur. it is unlisted. It has an authorized capital of ₹4.00 M and a paid-up capital of ₹3.99 M.
It upholds a compliant status. Its leadership includes Jyoti Shekhawat (Director), Preeti Agarwal (Director), Alka Kanoji (Director). Past directors included Preeti Agarwal, Alka Kanoji, Ghan Shyam Sharma. Its latest AGM occurred on 28 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No.-18, Basement Naman Plaza, Parbasi Nagar, Kedia Palace Crossing, Jaipur, Rajasthan, 302039.
U24299RJ2019PTC065317
065317
14 June 2019
₹4.00 M
₹3.99 M
Roc Jaipur
Unlisted
Active
Explore comprehensive insights into Rydan Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jyoti Shekhawat | Director | 14 Jun 2019 | Current |
| Preeti Agarwal | Director | 18 Oct 2019 | Current |
| Alka Kanoji | Director | 18 Oct 2019 | Current |
| Ankur Goyal | Director | 14 Jun 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 31 Dec 2020 | Past |
| Pramod Abcsdd | Additional Director | 31 Dec 2020 | Past |
| Pramod Abcsdd | Director | 08 Mar 2021 | Past |
| Pramod Abcsdd | Director | 18 Oct 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Rydan Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 68.35% increase. The company also saw a substantial improvement in profitability, with a 38.12% increase in profit. The company's net worth observed a substantial decline by a decrease of 97.23%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Rydan Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Rydan Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Rydan Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rydan Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Rydan Pharmaceuticals Private Limited last Annual general meeting of members was held on 28 Sep 2025 as per latest MCA records. was recorded as a recent event.
The activity Rydan Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Jaipur. was completed.
The activity Preeti Agarwal was appointed as a Director was appointed as a Director on 18 Oct 2019 & has been associated with this company since 6 years 2 months . was completed.
Alka Kanoji was appointed as a Director was appointed as a Director on 18 Oct 2019 & has been associated with this company since 6 years 2 months . was recorded as a recent event.
Progress on Jyoti Shekhawat was appointed as a Director was appointed as a Director on 14 Jun 2019 & has been associated with this company since 6 years 7 months . was documented.
Ankur Goyal was appointed as a Director was appointed as a Director on 14 Jun 2019 & has been associated with this company since 6 years 7 months . was recorded as a recent event.
The CIN of Rydan Pharmaceuticals Private Limited is U24299RJ2019PTC065317.
Rydan Pharmaceuticals Private Limited is headquartered at Plot No.-18, Basement Naman Plaza, Parbasi Nagar, Kedia Palace Crossing, Jaipur, Rajasthan, 302039.
Rydan Pharmaceuticals Private Limited was incorporated on 14 June 2019.
The current directors of Rydan Pharmaceuticals Private Limited are
The primary industry of Rydan Pharmaceuticals Private Limited is Trade.
Rydan Pharmaceuticals Private Limited is unlisted.
The authorized capital of Rydan Pharmaceuticals Private Limited is ₹4.00 M, and the paid-up capital is ₹3.99 M.
The compliance status of Rydan Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX